{"url_path":"/sec/adil/8-k/2026-06-11/item-2-01","section_key":"item-2-01","section_title":"Item 2.01 Completion of Acquisition","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/1513525/0001213900-26-067711-index.html","accession_number":"0001213900-26-067711","cik":"0001513525","ticker":"ADIL","issuer_name":"ADIAL PHARMACEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1513525/0001213900-26-067711-index.html","primary_entity_key":"0001513525","primary_entity_name":"ADIAL PHARMACEUTICALS, INC."},"word_count":39,"has_tables":true,"body_markdown":"**Item 2.01 - Completion of Acquisition\nor Disposition of Assets.**\n\n \n\nOn June 11, 2026, the Company completed its acquisition\nof Azora. The information contained in Item 1.01 of this Current Report is incorporated by reference into this Item 2.01."}